{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T17:29:47Z","timestamp":1774978187415,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,9,7]]},"DOI":"10.7759\/cureus.10290","type":"journal-article","created":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T11:37:00Z","timestamp":1599478620000},"source":"Crossref","is-referenced-by-count":3,"title":["Reversing Bleeding Associated With Antiplatelet Use: The Role of Tranexamic Acid"],"prefix":"10.7759","author":[{"given":"Kyle","family":"Fischer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatema","family":"Bodalbhai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Awudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salim","family":"Surani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)","volume":"348","author":"CAPRIE Steering Committee","year":"1996","unstructured":"CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet. 1996, 348:1329-1339. 10.1016\/s0140-6736(96)09457-3","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.8145","article-title":"Effect of 1-month dual antiplatelet therapy followed by clopidogrel vs 12-month dual antiplatelet therapy on cardiovascular and bleeding events in patients receiving PCI: the STOPDAPT-2 randomized clinical trial","volume":"321","author":"Watanabe H","year":"2019","unstructured":"Watanabe H, Domei T, Morimoto T, et al.. Effect of 1-month dual antiplatelet therapy followed by clopidogrel vs 12-month dual antiplatelet therapy on cardiovascular and bleeding events in patients receiving PCI: the STOPDAPT-2 randomized clinical trial. JAMA. 2019, 321:2414-2427. 10.1001\/jama.2019.8145","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"crossref","DOI":"10.4065\/84.2.149","article-title":"Expanding the recognition and assessment of bleeding events associated with antiplatelet therapy in primary care","volume":"84","author":"Cohen M","year":"2009","unstructured":"Cohen M. Expanding the recognition and assessment of bleeding events associated with antiplatelet therapy in primary care. Mayo Clin Proc. 2009, 84:149-160.","journal-title":"Mayo Clin Proc"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.118.004945","article-title":"Tailoring antiplatelet therapy intensity to ischemic and bleeding risk","volume":"12","author":"Baber U","year":"2019","unstructured":"Baber U, Leisman DE, Cohen DJ, et al.. Tailoring antiplatelet therapy intensity to ischemic and bleeding risk. Circ Cardiovasc Qual Outcomes. 2019, 12:004945. 10.1161\/CIRCOUTCOMES.118.004945","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/ccm.0000000000002057","article-title":"Guideline for reversal of antithrombotics in intracranial hemorrhage: executive Summary. A statement for healthcare professionals from the Neurocritical Care Society and the Society of Critical Care Medicine","volume":"44","author":"Frontera JA","year":"2016","unstructured":"Frontera JA, Lewin JJI, Rabinstein AA, et al.. Guideline for reversal of antithrombotics in intracranial hemorrhage: executive Summary. A statement for healthcare professionals from the Neurocritical Care Society and the Society of Critical Care Medicine. Crit Care Med. 2016, 44:2251-2257. 10.1097\/ccm.0000000000002057","journal-title":"Crit Care Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/jth.13576","article-title":"Desmopressin for treatment of platelet dysfunction and reversal of antiplatelet agents: a systematic review and meta-analysis of randomized controlled trials","volume":"15","author":"Desborough MJ","year":"2017","unstructured":"Desborough MJ, Oakland KA, Landoni G, Crivellari M, Doree C, Estcourt LJ, Stanworth SJ. Desmopressin for treatment of platelet dysfunction and reversal of antiplatelet agents: a systematic review and meta-analysis of randomized controlled trials. J Thromb Haemost. 2017, 15:263-272. 10.1111\/jth.13576","journal-title":"J Thromb Haemost"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.8221","article-title":"Role of tranexamic acid in the clinical setting","volume":"12","author":"Fischer K","year":"2020","unstructured":"Fischer K, Awudi E, Varon J, Surani S. Role of tranexamic acid in the clinical setting. Cureus. 2020, 12:8221. 10.7759\/cureus.8221","journal-title":"Cureus"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00508-017-1194-y","article-title":"Tranexamic acid for treatment and prophylaxis of bleeding and hyperfibrinolysis","volume":"129","author":"Pabinger I","year":"2017","unstructured":"Pabinger I, Fries D, Sch\u00f6chl H, Streif W, Toller W. Tranexamic acid for treatment and prophylaxis of bleeding and hyperfibrinolysis. Wien Klin Wochenschr. 2017, 129:303-316. 10.1007\/s00508-017-1194-y","journal-title":"Wien Klin Wochenschr"},{"key":"ref9","article-title":"Tranexamic acid","author":"Chauncey JM","year":"2020","unstructured":"Chauncey JM, Wieters JS. Tranexamic acid. StatPearls [Internet]. StatPearls Publishing, Treasure Island, FL; 2020."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/EJA.0b013e32834050ab","article-title":"Tranexamic acid partially improves platelet function in patients treated with dual antiplatelet therapy","volume":"28","author":"Weber CF","year":"2011","unstructured":"Weber CF, G\u00f6rlinger K, Byhahn C, Moritz A, Hanke AA, Zacharowski K, Meininger D. Tranexamic acid partially improves platelet function in patients treated with dual antiplatelet therapy. Eur J Anaesthesiol. 2011, 28:57-62. 10.1097\/EJA.0b013e32834050ab","journal-title":"Eur J Anaesthesiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.118.035160","article-title":"Is there a role for preoperative platelet function testing in patients undergoing cardiac surgery during antiplatelet therapy?","volume":"138","author":"Mahla E","year":"2018","unstructured":"Mahla E, Tantry US, Pr\u00fcller F, Gurbel PA. Is there a role for preoperative platelet function testing in patients undergoing cardiac surgery during antiplatelet therapy?. Circulation. 2018, 138:2145-2159. 10.1161\/circulationaha.118.035160","journal-title":"Circulation"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.22088\/cjim.10.2.156","article-title":"The effect of low- dose tranexamic acid on postoperative blood loss in patients treated with clopidogrel and aspirin","volume":"10","author":"Banihashem N","year":"2019","unstructured":"Banihashem N, Khorasani M, Vaffai H, Naziri F, Khafri S, Seyfi S. The effect of low- dose tranexamic acid on postoperative blood loss in patients treated with clopidogrel and aspirin. Caspian J Intern Med. 2019, 10:156-161. 10.22088\/cjim.10.2.156","journal-title":"Caspian J Intern Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement","volume":"151","author":"Moher D","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement. Ann Intern Med. 2009, 151:264-269. 10.7326\/0003-4819-151-4-200908180-00135","journal-title":"Ann Intern Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-014-0579-0","article-title":"PICO, PICOS and SPIDER: a comparison study of specificity and sensitivity in three search tools for qualitative systematic reviews","volume":"14","author":"Methley AM","year":"2014","unstructured":"Methley AM, Campbell S, Chew-Graham C, McNally R, Cheraghi-Sohi S. PICO, PICOS and SPIDER: a comparison study of specificity and sensitivity in three search tools for qualitative systematic reviews. BMC Health Serv Res. 2014, 14:579. 10.1186\/s12913-014-0579-0","journal-title":"BMC Health Serv Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1253\/circj.cj-11-0811","article-title":"Effect of tranexamic acid on transfusion requirement in dual antiplatelet-treated anemic patients undergoing off-pump coronary artery bypass graft surgery","volume":"76","author":"Ahn SW","year":"2012","unstructured":"Ahn SW, Shim JK, Youn YN, et al.. Effect of tranexamic acid on transfusion requirement in dual antiplatelet-treated anemic patients undergoing off-pump coronary artery bypass graft surgery. Circ J. 2012, 76:96-101. 10.1253\/circj.cj-11-0811","journal-title":"Circ J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2013.1560","article-title":"Protective effects of tranexamic acid on clopidogrel before coronary artery bypass grafting: a multicenter randomized trial","volume":"148","author":"Shi J","year":"2013","unstructured":"Shi J, Ji H, Ren F, et al.. Protective effects of tranexamic acid on clopidogrel before coronary artery bypass grafting: a multicenter randomized trial. JAMA Surg. 2013, 148:538-547. 10.1001\/jamasurg.2013.1560","journal-title":"JAMA Surg"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-016-0251-1","article-title":"Bleeding complications during cardiac electronic device implantation in patients receiving antithrombotic therapy: is there any value of local tranexamic acid?","volume":"16","author":"Beton O","year":"2016","unstructured":"Beton O, Saricam E, Kaya H, et al.. Bleeding complications during cardiac electronic device implantation in patients receiving antithrombotic therapy: is there any value of local tranexamic acid?. BMC Cardiovasc Disord. 2016, 16:73. 10.1186\/s12872-016-0251-1","journal-title":"BMC Cardiovasc Disord"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1213\/01.ANE.0000054001.37346.03","article-title":"Single-dose tranexamic acid reduces postoperative bleeding after coronary surgery in patients treated with aspirin until surgery","volume":"96","author":"Pleym H","year":"2003","unstructured":"Pleym H, Stenseth R, Wahba A, Bjella L, Karevold A, Dale O. Single-dose tranexamic acid reduces postoperative bleeding after coronary surgery in patients treated with aspirin until surgery. Anesth Analg. 2003, 96:923-928. 10.1213\/01.ANE.0000054001.37346.03","journal-title":"Anesth Analg"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2007.10.003","article-title":"Aspirin and Tranexamic Acid for Coronary Artery Surgery (ATACAS) Trial: rationale and design","volume":"155","author":"Myles PS","year":"2008","unstructured":"Myles PS, Smith J, Knight J, et al.. Aspirin and Tranexamic Acid for Coronary Artery Surgery (ATACAS) Trial: rationale and design. Am Heart J. 2008, 155:224-230. 10.1016\/j.ahj.2007.10.003","journal-title":"Am Heart J"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1606424","article-title":"Tranexamic acid in patients undergoing coronary-artery surgery","volume":"376","author":"Myles PS","year":"2017","unstructured":"Myles PS, Smith JA, Forbes A, et al.. Tranexamic acid in patients undergoing coronary-artery surgery.  N Engl J Med. 2017, 376:136-148. 10.1056\/NEJMoa1606424","journal-title":"N Engl J Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/sux041","article-title":"Bleeding on dual antiplatelet therapy: real-life challenges","volume":"20","author":"Deshpande NV","year":"2018","unstructured":"Deshpande NV, Admane P, Mardikar HM. Bleeding on dual antiplatelet therapy: real-life challenges. Eur Heart J Suppl. 2018, 20:1-9. 10.1093\/eurheartj\/sux041","journal-title":"Eur Heart J Suppl"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010562.pub2","article-title":"Topical application of tranexamic acid for the reduction of bleeding","volume":"(7)","author":"Ker K","year":"2013","unstructured":"Ker K, Beecher D, Roberts I. Topical application of tranexamic acid for the reduction of bleeding. Cochrane Database Syst Rev. 2013, (7):010562. 10.1002\/14651858.CD010562.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref23","unstructured":"Tranexamic acid. (2020). Accessed. August 29, 2020: https:\/\/online.lexi.com\/."},{"key":"ref24","unstructured":"Desmopressin. (2020). Accessed. August 29, 2020: https:\/\/online.lexi.com\/."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/40782-reversing-bleeding-associated-with-antiplatelet-use-the-role-of-tranexamic-acid","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:26:17Z","timestamp":1707506777000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/40782-reversing-bleeding-associated-with-antiplatelet-use-the-role-of-tranexamic-acid"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,7]]},"references-count":24,"URL":"https:\/\/doi.org\/10.7759\/cureus.10290","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9,7]]}}}